Trial Profile
Phase III study of Miticure in paediatric patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 01 Oct 2015
Price :
$35
*
At a glance
- Drugs House dust mite allergy immunotherapy-ALK Abello (Primary)
- Indications Allergic asthma
- Focus Adverse reactions; Therapeutic Use
- 01 Oct 2015 New trial record